Status:
UNKNOWN
Self-monitoring of Blood Glucose in Insulin-treated Patients With Type 2 Diabetes
Lead Sponsor:
Medical Research Foundation, The Netherlands
Collaborating Sponsors:
Sanofi
Conditions:
Diabetes Mellitus, Type 2
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Primary Objective: The objective of the study is to investigate the effect of a specific frequency of Self-monitoring of blood glucose (SMBG) on glycemic control and quality of life in patients with ...
Detailed Description
SUMMARY Rationale: Self-monitoring of blood glucose (SMBG) is an important tool in diabetes care to achieve and maintain good glycemic control. But how often 'should' the patient measure the capilla...
Eligibility Criteria
Inclusion
- Patients with insulin-treated diabetes type 2
- \> 18 years of age
- using 1 insulin injection daily,
- performing SMBG \> 1 year
- HbA1c ≤ 58 mmol/mol (\< 7.5%) in the preceding 12 months
- sufficient knowledge of the Dutch language.-
Exclusion
- no hypo-unawareness
- no serious co-morbidity (as judged by their own GP)
- patients who measure their blood glucose concentration (4 measurements a day) more than once a week on average
Key Trial Info
Start Date :
May 1 2011
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
July 1 2012
Estimated Enrollment :
150 Patients enrolled
Trial Details
Trial ID
NCT01460459
Start Date
May 1 2011
End Date
July 1 2012
Last Update
October 26 2011
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Diabetes Centre, Isala Clinics
Zwolle, Netherlands, 8025 BT